Enrolling Prostate Patients
The PACE Study: A randomized study comparing surgery, CyberKnife and conventional radiation therapy for early stage prostate.
The CyberKnife® Robotic Radiosurgery System has been FDA-cleared for more than 10 years. The first prostate cancer patient was treated in 2002 and since then thousands of prostate cancer patients worldwide have been treated with the CyberKnife System. A total of 14 peer-reviewed studies involving more than 700 patients have been published showing the efficacy of non-invasive CyberKnife prostate SBRT (stereotactic body radiation therapy) in terms of disease-free survival, toxicity, and preservation of sexual function. Accuray advises that patients discuss with their physicians their treatment options in order to determine which one is best for their individual case.
PACE Study Fact Sheet
Find even more information about the PACE study
Benefits of CyberKnife Prostate SBRT
Clinical Information
5-Year Outcomes
Published 5-year outcomes for CyberKnife prostate SBRT
Case Studies
SBRT vs. IMRT, Proton Radiation Therapy
Cost-effectiveness of SBRT versus IMRT and proton radiation therapy for localized prostate cancer
CyberKnife Compared to da Vinci Surgery for Prostate Treatment
Overview of CyberKnife prostate SBRT vs da Vinci surgery
Prostate SBRT Webinar
Addressing patient selection and comparisons with other radiation treatments for prostate cancer
Prostate Bibliography
Published clinical and technical CyberKnife articles
CyberKnife System
CyberKnife System
Overview of the CyberKnife VSI System
CyberKnife Prostate Solutions
Overview of CyberKnife prostate solutions
CyberKnife for Prostate
Overview of CyberKnife prostate treatments
InTempo
Solution to manage prostate motion
AERO
AERO Website
Accuray Exchange in Radiation Oncology (AERO)
Reimbursement
Medicare Map
U.S. Coverage of the CyberKnife System
Ongoing Research
Registry for Prostate Cancer Radiosurgery
The Registry for Prostate Cancer Radiosurgery (RCPR) is a multi-institutional IRB approved prospective observational trial. The goals of the registry include improved quality of care and improved patient access to Stereotactic Body Radiation Therapy (SBRT) for prostate cancer patients. RPCR is a nationwide trial that tracks prostate cancer patient demographics, treatment specifics, outcomes, and payor information.
Visit the RPCR Registry
Enrolling Prostate Patients
The PACE Study: A randomized study comparing surgery, CyberKnife and conventional radiation therapy for early stage prostate.
Click here to visit the website.
Patient Brochure
CyberKnife information for patients
Information Sheet
CyberKnife prostate information guide
CyberKnife Podcast
Listen to physicians discussing benefits of CyberKnife treatment
Resources for Your Doctor
A list of prostate related clinical and technical resources
Warren’s Cancer Chronicle: The Story of a CyberKnife Patient
Visit the CyberKnife Patient Website
Click here to visit our patient website and learn more about the CyberKnife System.
- What is CyberKnife?
- What Can CyberKnife Treat?
- Patient Stories
© 2007 - 2013 Accuray Incorporated. All Rights Reserved. Accuray, the stylized logo, CyberKnife, Synchrony, Xsight, Xchange, TomoHD, Hi•Art, and RoboCouch are among the trademarks and / or registered trademarks of Accuray Incorporated in the United States and other countries.